Home   »   Media   »   IdeaCity


In 2014, Dr. Fossel gave this short (17-minute) talk at IdeaCity, giving a clear and concise presentation of the rationale for and the history of telomerase therapy, as well as the plans for human trials.

Watch more

  • Telocyte LSX Presentation April 2020
  • Dr. Michael Fossel takes 10 minutes to explain where the field currently stands, why other approaches fail, and what Telocyte is about to do

  • The Science
  • Dr. Maria Blasco, the director of the CNIO (one of the world’s leading cancer institutes), discusses the data, the rationale, and the technology that underlie Telocyte’s approach to treating Alzheimer’s and other age-related diseases.

  • Introducing Telocyte™
  • Dr Michael Fossel and Peter Rayson tell why Telocyte™ was founded, how the therapy works, and how the program will demonstrate an effective cure for Alzheimer’s and other age-related dementias.